Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0000950123-99-009346
Filing Date
1999-10-15
Accepted
1999-10-15 00:00:00
Documents
4
Period of Report
1999-06-30

Document Format Files

Seq Description Document Type Size
1 OSI PHARMACEUTICALS 10-Q/A 27405
2 CONSENT OF KPMG LLP EX-23 860
3 AUDITED FINANCIAL STATEMENTS OF CADUS EX-99.1 87614
4 UNAUDITED PRO FORMA FINANCIAL INFORMATION EX-99.2 24827
  Complete submission text file 0000950123-99-009346.txt   142575
Mailing Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553-3649
Business Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553 5162220023
OSI PHARMACEUTICALS INC (Filer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q/A | Act: 34 | File No.: 000-15190 | Film No.: 99729593
SIC: 2835 In Vitro & In Vivo Diagnostic Substances